Chest, Vol 105, 190-194, Copyright © 1994 by American College of Chest Physicians

ARTICLES

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study

PM Suter, G Domenighetti, MD Schaller, MC Laverriere, R Ritz and C Perret
Department of Anesthesia, University Hospitals of Geneva, Switzerland.

OBJECTIVE: To determine the effects of intravenous N-acetylcysteine (NAC) on the development of severe adult respiratory distress syndrome (ARDS) and mortality rate in patients with mild-to-moderate acute lung injury and to analyze the duration of ventilatory support and FIO2 required as well as the evolution of the lung injury score. SETTING: Three university hospital ICUs and one regional ICU in Switzerland. PATIENTS: Sixty-one adult patients presenting with mild-to-moderate acute lung injury and various predisposing factors for ARDS received either NAC, 40 mg/kg/d, or placebo intravenously for 3 days. MEASUREMENTS: Respiratory dysfunction was assessed daily according to the need for mechanical ventilation and FIO2, the evolution of the lung injury score, and the PaO2/FIO2 ratio. The cardiovascular state, liver function, and kidney function were also monitored. Data were collected at admission (day 0), during the first 3 days, and on the day of discharge from the ICU. RESULTS: The NAC and placebo groups (32 and 29 patients, respectively) were comparable at ICU admission for severity of illness assessed by the simplified acute physiology score (SAPS) (10.8 +/- 4.6 vs 10.9 +/- 4.8) and lung injury score (LIS) (1.39 +/- 0.95 vs 1.11 +/- 1.08) (mean +/- SD). Three patients in each group developed ARDS. The 1-month mortality rate was 22 percent for the NAC group and 35 percent for the placebo group (difference not statistically significant). At admission, 22 of 32 patients (69 percent) in the NAC group were mechanically ventilated compared with 22 of 29 (76 percent) in the placebo group. At the end of the treatment period (day 3), 5 of 29 (17 percent) in the NAC group and 12 of 25 (48 percent) in the placebo group were still receiving ventilatory support (p = 0.01), The FIO2 was 0.37 less than admission value (day 0) in the NAC group, and 0.20 less in the placebo group (p < 0.04); the oxygenation index (PaO2/FIO2) improved significantly (p < 0.05) from day 0 to day 3 only in the NAC-treated group. The LIS showed a significant regression (p = 0.003) in the NAC-treated group during the first 10 days of treatment: no change was observed in the placebo group. No adverse effects were observed during the treatment with NAC. CONCLUSIONS: Intravenous NAC treatment during 72 h improved systemic oxygenation and reduced the need for ventilatory support in patients presenting with mild-to-moderate acute lung injury subsequent to a variety of underlying diseases. Development of ARDS and mortality were not reduced significantly by this therapy.

This article has been cited by other articles:

				S. G Raja and G. D Dreyfus Modulation of Systemic Inflammatory Response after Cardiac Surgery Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 382 - 395. [Abstract] [Full Text] [PDF]

				B. S. Burleson and E. D. Maki Acute Respiratory Distress Syndrome Journal of Pharmacy Practice, April 1, 2005; 18(2): 118 - 131. [Abstract] [PDF]

				C.-W. Chow, M. T. Herrera Abreu, T. Suzuki, and G. P. Downey Oxidative Stress and Acute Lung Injury Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 427 - 431. [Full Text] [PDF]

				W.A. Wuyts, B.M. Vanaudenaerde, L.J. Dupont, M.G. Demedts, and G.M. Verleden N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells Eur. Respir. J., July 1, 2003; 22(1): 43 - 49. [Abstract] [Full Text] [PDF]

				J. Sochman N-acetylcysteine in acute cardiology: 10 years later: What do we know and what would we like to know?! J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1422 - 1428. [Abstract] [Full Text] [PDF]

				S. Hammerschmidt, N. Buchler, and H. Wahn Tissue Lipid Peroxidation and Reduced Glutathione Depletion in Hypochlorite-Induced Lung Injury Chest, February 1, 2002; 121(2): 573 - 581. [Abstract] [Full Text] [PDF]

				J. Fan, R. D. Ye, and A. B. Malik Transcriptional mechanisms of acute lung injury Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1037 - L1050. [Abstract] [Full Text] [PDF]

				E. M. Bulger and R. V. Maier Antioxidants in Critical Illness Arch Surg, October 1, 2001; 136(10): 1201 - 1207. [Abstract] [Full Text] [PDF]

				N. S. Chandel, W. C. Trzyna, D. S. McClintock, and P. T. Schumacker Role of Oxidants in NF-{kappa}B Activation and TNF-{alpha} Gene Transcription Induced by Hypoxia and Endotoxin J. Immunol., July 15, 2000; 165(2): 1013 - 1021. [Abstract] [Full Text] [PDF]

				D. M. Guidot, K. Modelska, M. Lois, L. Jain, I. M. Moss, J.-F. Pittet, and L. A. S. Brown Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L127 - L135. [Abstract] [Full Text] [PDF]

				S. Abe, H. Takizawa, I. Sugawara, and S. Kudoh Diesel Exhaust (DE)-Induced Cytokine Expression in Human Bronchial Epithelial Cells . A Study with a New Cell Exposure System to Freshly Generated DE In Vitro Am. J. Respir. Cell Mol. Biol., March 1, 2000; 22(3): 296 - 303. [Abstract] [Full Text]

				M. MOSS, D. M. GUIDOT, M. WONG-LAMBERTINA, T. TEN HOOR, R. L. PEREZ, and L. A. S. BROWN The Effects of Chronic Alcohol Abuse on Pulmonary Glutathione Homeostasis Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 414 - 419. [Abstract] [Full Text]

				M. LOIS, L. A. S. BROWN, I. M. MOSS, J. ROMAN, and D. M. GUIDOT Ethanol Ingestion Increases Activation of Matrix Metalloproteinases in Rat Lungs during Acute Endotoxemia Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1354 - 1360. [Abstract] [Full Text]

				A Y T Goh, P W K Chan, L C S Lum, and M Roziah Incidence of acute respiratory distress syndrome: a comparison of two definitions Arch. Dis. Child., September 1, 1998; 79(3): 256 - 259. [Abstract] [Full Text]

				J. Fan, J. C. Marshall, M. Jimenez, P. N. Shek, J. Zagorski, and O. D. Rotstein Hemorrhagic Shock Primes for Increased Expression of Cytokine-Induced Neutrophil Chemoattractant in the Lung: Role in Pulmonary Inflammation Following Lipopolysaccharide J. Immunol., July 1, 1998; 161(1): 440 - 447. [Abstract] [Full Text] [PDF]

				R. CORINNE SPRONG, A.M. L.  WINKELHUYZEN-JANSSEN, C. J. M. AARSMAN, J. F. L. M. van OIRSCHOT, T. van der BRUGGEN, and B. SWEDER van ASBECK Low-dose N-Acetylcysteine Protects Rats against Endotoxin-mediated Oxidative Stress, But High-dose Increases Mortality Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1283 - 1293. [Abstract] [Full Text] [PDF]

				A. ARTIGAS, G. R. BERNARD, J. CARLET, D. DREYFUSS, L. GATTINONI, L. HUDSON, M. LAMY, J. J. MARINI, M. A. MATTHAY, M. R. PINSKY, et al. The American-European Consensus Conference on ARDS, Part 2 . Ventilatory, Pharmacologic, Supportive Therapy, Study Design Strategies, and Issues Related to Recovery and Remodeling Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1332 - 1347. [Abstract] [Full Text] [PDF]

				A. B. Nathens, R. Bitar, R. W.G. Watson, T. B. Issekutz, J. C. Marshall, A. P.B. Dackiw, and O. D. Rotstein Thiol-Mediated Regulation of ICAM-1 Expression in Endotoxin-Induced Acute Lung Injury J. Immunol., March 15, 1998; 160(6): 2959 - 2966. [Abstract] [Full Text] [PDF]

				A. B. Nathens, R. Bitar, C. Davreux, M. Bujard, J. C. Marshall, A. P. B. Dackiw, R. W. G. Watson, and O. D. Rotstein Pyrrolidine Dithiocarbamate Attenuates Endotoxin-induced Acute Lung Injury Am. J. Respir. Cell Mol. Biol., November 1, 1997; 17(5): 608 - 616. [Abstract] [Full Text]

				M. H. Kollef and D. P. Schuster The Acute Respiratory Distress Syndrome N. Engl. J. Med., January 5, 1995; 332(1): 27 - 37. [Full Text] [PDF]